HORIZON THERAPEUTICS
Horizon Therapeutics is a specialty and generic drug manufacturing company. The company is focused on researching, developing, and commercializing medicines that address critical needs for people impacted by rare and rheumatic diseases. The company has two reportable segments: the orphan and rheumatology segment and the inflammation segment. It markets medicines in the areas of orphan diseases, rheumatology and inflammation division.
HORIZON THERAPEUTICS
Industry:
Biopharma Biotechnology Health Care Manufacturing
Founded:
2008-01-01
Status:
Active
Total Funding:
2.7 B USD
Similar Organizations
Acceleron Pharma
Acceleron is a biopharmaceutical company engaged in developing, manufacturing and commercializing novel biotherapeutics.
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Asklepios BioPharmaceutical
Asklepios BioPharmaceutical is a biotechnology company developing adeno-associated virus (AAV) gene therapies for genetic disorders.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
FORMA Therapeutics
FORMA Therapeutics is a biopharmaceutical company focused on the discovery, development, and commercialization of transformative medicines.
Fulcrum Therapeutics
Fulcrum Therapeutics is a biotechnology company that develops new medicines to treat patients with rare genetic diseases.
Innovent Biologics
Innovent Biologics is a biopharmaceutical company that develops and manufactures monoclonal antibodies.
NTpharma
NTpharma provides GMP production of nanovaccines and biopharmaceuticals containing carbohydrate binders.
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Employees Featured
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-02-01 | Viela Bio | Viela Bio acquired by Horizon Therapeutics | 3.05 B USD |
| 2020-04-02 | Curzion Pharmaceuticals | Curzion Pharmaceuticals acquired by Horizon Therapeutics | N/A |
| 2016-10-25 | Raptor Pharmaceuticals | Raptor Pharmaceuticals acquired by Horizon Therapeutics | N/A |
| 2015-05-07 | Hyperion Therapeutics | Hyperion Therapeutics acquired by Horizon Therapeutics | N/A |
| 2014-09-19 | Vidara Therapeutics | Vidara Therapeutics acquired by Horizon Therapeutics | N/A |
Investors List
Silicon Valley Bank
Silicon Valley Bank investment in Post-IPO Debt - Horizon Therapeutics
Oxford Finance LLC
Oxford Finance LLC investment in Post-IPO Debt - Horizon Therapeutics
Kreos Capital
Kreos Capital investment in Post-IPO Debt - Horizon Therapeutics
Key Employee Changes
More informations about "Horizon Therapeutics"
AMGEN COMPLETES ACQUISITION OF HORIZON …
Oct 6, 2023 Advances Amgen's Mission to Serve Patients With First-in-Class Rare Disease Medicines. THOUSAND OAKS, Calif., Oct. 6, 2023 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced that it has completed its …See details»
Horizon Therapeutics Canada | Patient Support
If you would like to learn more about the services offered by TranscendRareâ„¢, contact us: Call 1-844-380-7850 Monday to Friday 8am – 8pm (EST) or; Email us at transcendrare@innomar …See details»
Horizon - The Org
Horizon Therapeutics plc is an Irish–tax registered pharmaceutical company that acquires, rebrands, repackages, and reprices specialist drugs for sale into the US healthcare system, …See details»
Horizon Therapeutics Company Profile 2024: Valuation, …
Horizon Therapeutics’s most recent deal was a Corporate Asset Purchase with EirGen Pharma (Drug Product Manufacturing Facility in Waterford, Ireland) for . The deal was made on 01-Jul-2021. The deal was made on 01-Jul-2021.See details»
Horizon Therapeutics Company Profile - Craft
Horizon Therapeutics is a biopharmaceutical company focused on researching, developing, and commercializing medicines. It offers products to treat rare, autoimmune, and inflammatory …See details»
Amgen close to deal to buy Horizon Therapeutics for …
Dec 11, 2022 Amgen is close to a deal to acquire Horizon Therapeutics in a transaction worth as much as $20bn, according to sources familiar with the matter, as a sell-off in healthcare stocks creates ...See details»
Q32 Bio and Horizon Therapeutics Announce Collaboration in …
Aug 15, 2022 Waltham, Mass. and Dublin – August 15, 2022 — Q32 Bio, a clinical stage biotechnology company developing biologic therapeutics to restore immune homeostasis, and …See details»
Organization | Horizon Therapeutics, LLC
Organization Overview. First Clinical Trial. 2010 NCT01257737. First Marketed Drug. 2006 ... HORIZON THERAP | Horizon Therapeutics | HORIZON THERAPEUTICS IRELAND | Horizon …See details»
An Overview of Horizon Therapeutic’s Drug Pipeline
Sep 8, 2023 In summary, Horizon Therapeutics Plc is a pharmaceutical organization based in Dublin, Ireland, specializing in the field of biomedicine. The company has a diverse portfolio of drugs targeting various therapeutic areas, …See details»
Cooley Secures Decisive Victory on Behalf of Horizon Therapeutics …
Washington, DC – September 8, 2023 – Cooley successfully defended long-time client Horizon Therapeutics, a specialty biopharmaceutical company, against a US Federal Trade …See details»
Horizon Therapeutics Profile: Summary - OpenSecrets
Horizon Therapeutics organization profile. Contributions in the 2022 cycle: $344,318. Lobbying in 2021: $5,050,000. Outside Spending in the 2022 cycle: $0.See details»
Horizon Pharma - Crunchbase Company Profile & Funding
Horizon Pharma may be growing as evidenced by its recent acquisition of Hyperion Therapeutics, Inc., which suggests an expansion of its product portfolio and market reach. Additionally, the …See details»
Horizon Therapeutics: Business Model, SWOT Analysis, and …
May 26, 2024 Horizon Therapeutics is a biopharmaceutical company that specializes in researching, developing, and commercializing innovative medicines for rare diseases and …See details»
Working at Horizon Therapeutics: 72 Reviews | Indeed.com
Jul 16, 2024 72 reviews from Horizon Therapeutics employees about Horizon Therapeutics culture, salaries, benefits, work-life balance, management, job security, and ... fair, optimistic, …See details»
Horizon Therapeutics (HZNP-Q) Stock Price and News
Real-time Price Updates for Horizon Therapeutics (HZNP-Q), along with buy or sell indicators, analysis, charts, historical performance, news and moreSee details»
Horizon Therapeutics - Fortune
We are treated as valuable to the organization. The company supports us at work and provides benefits to make us our best selves, professionally and personally. ... "Horizon Therapeutics …See details»
Horizon Pharma - Funding, Financials, Valuation & Investors
Which types of acquisition does this organization make most frequently? Show . Acquiree Name . Announced Date . Price . Transaction Name . Viela Bio . Feb 1, 2021: $3.1B: ... May 8, 2017: …See details»
Hoover v. Horizon Therapeutics USA, Inc. 1:2024cv12833 | US …
2 days ago Horizon Therapeutics USA, Inc. Case Number: 1:2024cv12833: Filed: December 13, 2024: Court: US District Court for the Northern District of Illinois: Presiding Judge: Thomas M …See details»
Organization | Horizon Therapeutics, LLC - CDEK
Organization Overview. First Clinical Trial. 2010 NCT01257737. First Marketed Drug. 2006 ... HORIZON THERAP | Horizon Therapeutics | HORIZON THERAPEUTICS IRELAND | Horizon …See details»
On the horizon: upcoming new agents for the management of ITP
Dec 6, 2024 Michele P. Lambert; On the horizon: upcoming new agents for the management of ITP. Hematology Am Soc Hematol Educ Program 2024; 2024 (1): 692–699. doi: ... This review …See details»